Pharmabiz

US FDA accepts for review Inovio's BLA for INO-3107 to treat adults with recurrent respiratory papillomatosis

Plymouth Meeting, Pennsylvania Tuesday, December 30, 2025, 15:00 Hrs [IST] ...